Tae-Bong Kang
Overview
Explore the profile of Tae-Bong Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
2354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Yang S, Park S, Kweon S, Ma G, Seo M, et al.
ACS Nano
. 2025 Jan;
19(2):2870-2889.
PMID: 39761412
The tumor-specific efficacy of the most current anticancer therapeutic agents, including antibody-drug conjugates (ADCs), oligonucleotides, and photosensitizers, is constrained by limitations such as poor cell penetration and low drug delivery....
2.
Byun K, Kim B, Cho J, Lee I, Lee M, Park D, et al.
Biomolecules
. 2023 Oct;
13(10).
PMID: 37892190
Although single-chain variable fragment (scFv) is recognized as a highly versatile scaffold of recombinant antibody fragment molecules, its overexpression in often leads to the formation of inclusion bodies. To address...
3.
Lee J, Yang S, Lee J, Lim H, Lee S, Kang T, et al.
Carbohydr Polym
. 2023 May;
314:120930.
PMID: 37173028
Heparin is a glycosaminoglycans (GAGs) member and well-known FDA-approved anticoagulant that has been widely used in the clinic for 100 years. It has also been evaluated in various fields for...
4.
Park S, Lee J, Yang S, Lee D, Kang T, Park J
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111617
Numerous cathepsin B inhibitors have been developed and are under investigation as potential cancer treatments. They have been evaluated for their ability to inhibit cathepsin B activity and reduce tumor...
5.
Kang J, Lee S, Seok J, Kim D, Ma G, Park J, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047051
The NLRP3 inflammasome serves as a host defense mechanism against various pathogens, but there is growing evidence linking its activation in sterile condition to diverse inflammatory diseases. Therefore, the identification...
6.
Lee S, Kang J, Sim E, Jung Y, Kim J, Hillman P, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982727
The AIM2 inflammasome is an innate immune system component that defends against cytosolic bacteria and DNA viruses, but its aberrant activation can lead to the progression of various inflammatory diseases,...
7.
Jin L, Yun D, Zhang W, Lee J, Shin H, Kim D, et al.
Materials (Basel)
. 2023 Feb;
16(4).
PMID: 36836964
Recently, developments in the field of cosmetics have led to a renewed interest in hair dyeing. However, damage to the hair during the dyeing process has increased hesitation in attempting...
8.
Kim S, Kang T, Kim D, Keum M, Lee S, Kim J, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358242
Natural antimicrobial peptides (AMPs) are multifunctional host defense peptides (HDPs) that are valuable for various therapeutic applications. In particular, natural and artificial AMPs with dual antibacterial immunomodulatory functions emerged as...
9.
Sun X, Kang T, Lee K
Methods Mol Biol
. 2022 Feb;
2459:137-147.
PMID: 35212962
Sepsis is a complex disorder related to dysregulation of the host response to infection and is a major health problem worldwide owing to its high mortality rates. However, the exact...
10.
Banik N, Yang S, Kang T, Lim J, Park J
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638867
Heparin has been extensively studied as a safe medicine and biomolecule over the past few decades. Heparin derivatives, including low-molecular-weight heparins (LMWH) and heparin pentasaccharide, are effective anticoagulants currently used...